Maturitas
Volume 59, Issue 3 , Pages 281-282 , 20 March 2008

The short-term effect of increased body weight in menopausal Chinese women taking tibolone

  • Peng-Hui Wang

      Affiliations

    • Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taiwan
    • Institute of Clinical Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan
    • ,
  • Ming-Shyen Yen

      Affiliations

    • Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taiwan
    • Institute of Clinical Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan
    • ,
  • Kuan Chong Chao

      Affiliations

    • Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taiwan
    • Institute of Clinical Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan
  • Chi-Ming Liu

      Affiliations

    • Department of Surgery, Cheng Hsin Rehabilitation Center-Taipei, Taiwan
    • Community Medicine Research Center & Institute of Public Health, National Yang-Ming University, Taiwan
  • Wen-Ling Lee

      Affiliations

    • Division of Endocrinology and Metabolism, Department of Medicine, Cheng Hsin Rehabilitation Center-Taipei, Taiwan
    • Institute of Clinical Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan
    • Corresponding Author InformationCorresponding author at: Division of Endocrinology and Metabolism, Department of Medicine, Cheng Hsin Rehabilitation Center-Taipei, Taiwan.

Received 9 October 2007

References 

  1. Jacobsen DE, Samson MM, Kezic S, Verhaar HJJ. Postmenopausal HRT and tibolone in relation to muscle strength and body composition. Maturitas. 2007;58:7–18
  2. Writing Group for the Women's Health Initiative Investigators . Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321–333
  3. Wang PH, Horng HC, Cheng MH, Chao HT, Chao KC. Standard and low-dose hormone therapy for postmenopausal women-Focus on the breast. Taiwan J Obstet Gynecol. 2007;46:127–134
  4. Wang PH, Cheng MH, Chao HT, Chao KC. Tibolone in the breast of postmenopausal women. Taiwan J Obstet Gynecol. 2007;46:121–126
  5. Chao KC, Wang PH, Yen MS, et al. New selective tissue estrogenic activity regulator in menopausal therapy in Taiwan. Taiwan J Obstet Gynecol. 2005;44:327–331
  6. Bianco V, Murina F, Roberti P, Valente I. Tibolone in the treatment of menopause: compliance, efficacy and safety in a ten-year experience. Minerva Ginecol. 2006;58:335–344
  7. Gol M, Ozsener S, Sendag F, et al. Does tibolone affect serum leptin levels and body weight in postmenopausal women?. Arch Gynecol Obstet. 2005;272:127–130
  8. Boyanov MA, Shinkov AD. Effects of tibolone on body composition in postmenopausal women: a 1-year follow up study. Maturitas. 2005;51:363–369
  9. Pasarica M, Zachwieja JJ, Dejonge L, Redman S, Smith SR. Effect of growth hormone on body composition and visceral adiposity in middle aged men with visceral obesity. J Clin Endocrinol Metab. 2007;92:4265–4270

PII: S0378-5122(07)00296-4

doi: 10.1016/j.maturitas.2007.10.013

Maturitas
Volume 59, Issue 3 , Pages 281-282 , 20 March 2008

Article Tools